Evidence map›Paper›PMID 41120815›Full record

ArticleThe journal of physical chemistry letters2025

Correlations in the Binding Energy of Triexcitons and Biexcitons in Single CdSe/CdS Nanoplatelets Revealed by Heralded Spectroscopy.

Daniel Amgar, Dekel Nakar, Nadav Frenkel, Dan Oron

Abstract read
In one paragraph

Article in The journal of physical chemistry letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel AmgarDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0001-8379-187X
Dekel NakarDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0003-3814-7115
Nadav FrenkelDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 76100, Israel.
Dan OronDepartment of Molecular Chemistry and Materials Science, Weizmann Institute of Science, Rehovot 76100, Israel.ORCID 0000-0003-1582-8532

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Semiconductor nanoplatelets present reduced Auger recombination, giving rise to enhanced multiexciton emission. This virtue makes them good candidates to investigate higher-order carrier dynamics, allowing extraction of important excitonic properties, such as biexciton and triexciton binding energies that highly influence applications involving high excitation fluxes. Here, we explore triexciton emission, emanating from single core/shell CdSe/CdS nanoplatelets. We apply heralded postselection of photon triplets using an advanced home-built single-photon spectrometer in order to resolve the triexciton-biexciton-exciton-ground state cascaded relaxation in both time and spectrum, and unambiguously determine the triexciton relaxation route and interaction nature. The results show a characteristic blue shift of the biexciton and triexciton, pointing to repulsive multiexciton interaction in the nanoplatelets under study. The relatively small measured energy shift of the triexciton (5.9 ± 0.7 meV) indicates that it recombines through the 1S bands rather than the 1P bands, in agreement with findings on other colloidal quantum dot systems. Most importantly, the strong correlation between the biexciton and triexciton binding energies, and the ability to tune them via control of the particle dimensions and composition, paves the way for developing emitters of nearly degenerate photon triplets.

Identifiers

PMID41120815
PMCPMC12581158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.